EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Transforming growth factor-β in kidney disease in dogs and cats: a review of the evidence of its role in renal fibrosis

Rachel E Cianciolo iD, Jonathan Elliott iD, Mary B Nabity iD, Jonathan D Foster iD, Dylan T Ammons iD, Katrina Bartas iD, Tracey Williams iD, Elizabeth A VanBeelen iD, Lindsay Weaver iD

Journal of Veterinary Internal Medicine · 2026

DOI: 10.1093/jvimsj/aalag206 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Veterinary Internal Medicine, 2026. Verfasst von Rachel E Cianciolo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Anatomic Pathology, Zoetis Reference Labs, Parsippany, NJ, United States. Hauptthemen laut MEDLINE: Cat Diseases, Transforming Growth Factor beta, Dog Diseases, Renal Insufficiency, Chronic. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A growing body of literature implicates the transforming growth factor (TGF)-β pathway in the progression of chronic kidney disease (CKD) in dogs and cats by promoting renal fibrosis. In rodents and humans, TGF-β is a key player in development of glomerulosclerosis and renal interstitial fibrosis. The pathway is also immunomodulatory, underscoring the complexity of its downstream effects. Recently, evidence for the role of TGF-β in small animal CKD has been presented using multiple methodologies, including serum and urinary biomarkers, as well as gene and protein expression in renal tissue and primary renal cell cultures. The aim of this review is to integrate these data and highlight consistencies and discrepancies in the literature. Some of the most convincing data supporting the role of the TGF-β pathway includes biomarker levels and pathway analysis of transcriptional profiles in spontaneous CKD in cats and in the X-linked Alport model in dogs. Demonstration of the presence of TGF-β protein is challenging due to lack of commercially available immunohistochemistry (IHC) antibodies that are sensitive and specific for active variants and isoforms TGF-β in dogs and cats. Cross-reactivity of IHC antibodies with latent TGF-β isoforms (complexed with extracellular matrix proteins) complicates the interpretation of IHC labeling. The mechanisms by which TGF-β activates fibroblasts and injures glomeruli in small animals is an area for future research. Although the relationship between TGF-β and glomerulosclerosis is mostly theoretical based on extrapolation from humans and rodents, substantial evidence strongly supports a role for TGF-β in renal interstitial scarring of small animals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cat DiseasesTransforming Growth Factor betaDog DiseasesRenal Insufficiency, ChronicKidney DiseasesAnimalsDogsCatsFibrosisKidneyBiomarkers

Stichwörter der Autor:innen

catsdogsglomerulosclerosistransforming growth factor-βchronic kidney disease

Substanzen

Transforming Growth Factor betaBiomarkers

Autor:innen und Institutionen

  • Anatomic Pathology, Zoetis Reference Labs, Parsippany, NJ, United States.
  • Department of Comparative Biomedical Sciences, The Royal Veterinary College, University of London, London, United Kingdom.
  • Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States.
  • Department of Nephrology, Urology and Extracorporal Therapies, Friendship Animal Hospital, Bethesda, MD, United States.
  • Veterinary Medicine Research and Development, Zoetis, Kalamazoo, MI, United States.

ORCID-Profile: Rachel E Cianciolo, Jonathan Elliott, Mary B Nabity, Jonathan D Foster, Dylan T Ammons, Katrina Bartas, Tracey Williams, Elizabeth A VanBeelen, Lindsay Weaver

Zitieren

APA

Cianciolo, R. E., Elliott, J., Nabity, M. B., Foster, J. D., Ammons, D. T., Bartas, K., Williams, T., VanBeelen, E. A., & Weaver, L. (2026). Transforming growth factor-β in kidney disease in dogs and cats: a review of the evidence of its role in renal fibrosis. Journal of Veterinary Internal Medicine. https://doi.org/10.1093/jvimsj/aalag206

Vancouver

Cianciolo RE, Elliott J, Nabity MB, Foster JD, Ammons DT, Bartas K, et al. Transforming growth factor-β in kidney disease in dogs and cats: a review of the evidence of its role in renal fibrosis. Journal of Veterinary Internal Medicine. 2026. doi:10.1093/jvimsj/aalag206

BibTeX
@article{Cianciolo2026,
  author = {Cianciolo, Rachel E and Elliott, Jonathan and Nabity, Mary B and Foster, Jonathan D and Ammons, Dylan T and Bartas, Katrina and Williams, Tracey and VanBeelen, Elizabeth A and Weaver, Lindsay},
  title = {Transforming growth factor-β in kidney disease in dogs and cats: a review of the evidence of its role in renal fibrosis},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2026},
  doi = {10.1093/jvimsj/aalag206}
}
Kostenlos starten →